Rodman David Malcom bought MLYS
February 19, 2026 · Form 4 insider transaction
Rodman David Malcom bought 38,400 shares of Mineralys Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
38,400
Price
$0.00
Total value
N/A
InsiderRodman David Malcom
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 19, 2026
Filing dateFebruary 20, 2026
Shares owned after82,489
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting. The RSUs vest in annual installments over a period of four years, with 1/4th of the total shares underlying the RSU vesting on each one-year anniversary of the date of grant.